Advances of nanoparticles as drug delivery systems for disease diagnosis and treatment
Decades have passed since the first nanoparticles-base medicine was approved for human
cancer treatment, and the research and development of nanoparticles for drug delivery are …
cancer treatment, and the research and development of nanoparticles for drug delivery are …
[HTML][HTML] A review: Deep learning for medical image segmentation using multi-modality fusion
… negative (FN) and true negative (TN), ∂ S and ∂ R are the sets of lesion border pixels/voxels
for … of voxels in the algorithm segmentation, X s and Y s are the sets of surface points of the …
for … of voxels in the algorithm segmentation, X s and Y s are the sets of surface points of the …
[HTML][HTML] Materials development and potential applications of transparent ceramics: A review
Transparent ceramics have various potential applications such as infrared (IR) windows/domes,
lamp envelopes, opto-electric components/devices, composite armors, and screens for …
lamp envelopes, opto-electric components/devices, composite armors, and screens for …
[HTML][HTML] A trial of lopinavir–ritonavir in adults hospitalized with severe Covid-19
…, X Dong, Z Qu, S Lu, X Hu, S Ruan, S Luo… - New England journal …, 2020 - Mass Medical Soc
Background No therapeutics have yet been proven effective for the treatment of severe
illness caused by SARS-CoV-2. Methods We conducted a randomized, controlled, open-label …
illness caused by SARS-CoV-2. Methods We conducted a randomized, controlled, open-label …
[HTML][HTML] Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
…, Y Hu, G Luo, K Wang, Y Lu, H Li, S Wang, S Ruan… - The lancet, 2020 - thelancet.com
Background No specific antiviral drug has been proven effective for treatment of patients
with severe coronavirus disease 2019 (COVID-19). Remdesivir (GS-5734), a nucleoside …
with severe coronavirus disease 2019 (COVID-19). Remdesivir (GS-5734), a nucleoside …
[HTML][HTML] Kinetics of viral load and antibody response in relation to COVID-19 severity
Y Wang, L Zhang, L Sang, F Ye, S Ruan… - The Journal of …, 2020 - Am Soc Clin Investig
… Anti–SARS-CoV-2 S and N IgG levels exhibited a moderate correlation with neutralization
titers in patients’ plasma. This study improves our understanding of immune response in …
titers in patients’ plasma. This study improves our understanding of immune response in …
[PDF][PDF] On the zeros of transcendental functions with applications to stability of delay differential equations with two delays
S Ruan, J Wei - Dynamics of Continuous Discrete and Impulsive …, 2003 - researchgate.net
… . studied the second degree exponential polynomials; Ruan [41] studied the distribution of
… of predatorprey systems, see also Martin and Ruan [33]; Ruan and Wei [42] analyzed a third …
… of predatorprey systems, see also Martin and Ruan [33]; Ruan and Wei [42] analyzed a third …
bcl-2 and p53 Oncoprotein Expression during Colorectal Tumorigenesis
FA Sinicrope, SB Ruan, KR Cleary, LC Stephens… - Cancer research, 1995 - AACR
Apoptosis or programmed cell death represents a mechanism by which cells possessing
DNA damage can be deleted. The bcl-2 proto-oncogene is a known inhibitor of apoptosis that …
DNA damage can be deleted. The bcl-2 proto-oncogene is a known inhibitor of apoptosis that …
Multi-task deep learning based CT imaging analysis for COVID-19 pneumonia: Classification and segmentation
… (loss glob) for the 3 tasks is defined by:(9) l o s s _ g l o b = L r e c o n + L s e g + L c l a s s …
The activation function is e l u for all layers except the last one which is a s i g m o i d . The loss …
The activation function is e l u for all layers except the last one which is a s i g m o i d . The loss …
A delay-differential equation model of HIV infection of CD4+ T-cells
RV Culshaw, S Ruan - Mathematical biosciences, 2000 - Elsevier
… The reduced ODE model is d T d t =s−μ T T+rT 1− T+I T max −k 1 VT, (2.1) d I d t =k ′ 1 VT−…
To explain the parameters, we note that s is the source of CD4 + T-cells from precursors, μ T …
To explain the parameters, we note that s is the source of CD4 + T-cells from precursors, μ T …
